GH Research Plc (GHRS)

23.43 -0.41 (-1.72%) USD  |  NASDAQ  |  Sep 28, 16:00
23.42 -0.01 (-0.04%) After-Hours: 20:00
More

GH Research Cash from Operations (Annual) : -43.55M for Dec. 31, 2025

Cash from Operations (Annual) Chart

View Cash from Operations (Annual) for GHRS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Annual) Chart
Start Trial

Historical Cash from Operations (Annual) Data

View and export this data back to 2019. Start Trial.
Date Value
December 31, 2025 -43.55M
December 31, 2024 -42.28M
December 31, 2023 -33.34M
December 31, 2022 -26.20M
Date Value
December 31, 2021 -15.28M
December 31, 2020 -0.33M
December 31, 2019 -0.289M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Annual) Range, Past 5 Years

View Cash from Operations (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Annual) Benchmarks

View Cash from Operations (Annual) Benchmarks
Start Trial
Eli Lilly & Co. 16.81B
Avadel Pharmaceuticals Plc --
Jazz Pharmaceuticals Plc 1.356B
Cosmo NV -13.02M
Johnson & Johnson 24.53B